Data di Pubblicazione:
2017
Citazione:
GPR17 Receptor Modulators / M. Abbracchio, M. Battaglia, I. Eberini, M. Fumagalli, C. Parravicini, C. Sensi, P. Zaratin.
Abstract:
The present invention relates to chemical compounds acting through GPR17 receptor for use in the treatment of diseases, in particular for use in chronic and/or acute neurodegenerative diseases, preferably Multiple Sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, renal diseases.
Tipologia IRIS:
09 - Brevetto, privativa o norma
Elenco autori:
M. Abbracchio, M. Battaglia, I. Eberini, M. Fumagalli, C. Parravicini, C. Sensi, P. Zaratin
Link alla scheda completa: